Comparing INVO Fertility (NASDAQ:IVF) & Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ)

INVO Fertility (NASDAQ:IVF) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Analyst Ratings

This is a summary of recent recommendations for INVO Fertility and Health Sciences Acquisitions Co. 2, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1	0	0	0	1.00
Health Sciences Acquisitions Co. 2	0	0	0	0	0.00

Volatility and Risk

INVO Fertility has a beta of 2.54, meaning that its share price is 154% more volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500.

Institutional & Insider Ownership

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 0.7% of INVO Fertility shares are owned by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares INVO Fertility and Health Sciences Acquisitions Co. 2’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%

Valuation & Earnings

This table compares INVO Fertility and Health Sciences Acquisitions Co. 2″s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53 million	0.31	-$9.10 million	($630.30)	0.00
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380,000.00	N/A	N/A

Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than INVO Fertility.

Summary

Health Sciences Acquisitions Co. 2 beats INVO Fertility on 5 of the 8 factors compared between the two stocks.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

About Health Sciences Acquisitions Co. 2

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.